{"log_id": 7328436690437705185, "direction": 0, "words_result_num": 39, "words_result": [{"probability": {"variance": 0, "average": 0.999245, "min": 0.998259}, "location": {"width": 107, "top": 145, "height": 25, "left": 129}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999446, "min": 0.999119}, "location": {"width": 82, "top": 191, "height": 25, "left": 159}, "words": "药理作用"}, {"probability": {"variance": 0.000115, "average": 0.99511, "min": 0.941463}, "location": {"width": 911, "top": 235, "height": 43, "left": 158}, "words": "盐酸金刚乙胺为合成的抗病毒药,主要对A型流感病毒具有活性。本品的作用机理尚不完全清楚,可能"}, {"probability": {"variance": 0.002011, "average": 0.991144, "min": 0.688433}, "location": {"width": 944, "top": 281, "height": 43, "left": 121}, "words": "是通过抑制病毒脱壳,从而在病毒复制的早期环节起作用。遗传学研究提示,由病毒颗粒M基因编码的一种"}, {"probability": {"variance": 0.000252, "average": 0.993625, "min": 0.908512}, "location": {"width": 926, "top": 330, "height": 41, "left": 120}, "words": "蛋白,在金刚乙胺抑制敏感A型流感病毒中起重要作用。本品不影响灭活的A型流感病毒疫苗的免疫原性"}, {"probability": {"variance": 2.5e-05, "average": 0.995788, "min": 0.98723}, "location": {"width": 79, "top": 379, "height": 23, "left": 159}, "words": "毒理研究"}, {"probability": {"variance": 0.019439, "average": 0.856971, "min": 0.717547}, "location": {"width": 106, "top": 390, "height": 46, "left": 842}, "words": "有限"}, {"probability": {"variance": 1.2e-05, "average": 0.997263, "min": 0.986448}, "location": {"width": 604, "top": 422, "height": 35, "left": 157}, "words": "遗传毒性:在进行的数项标准致突变试验中,未见本品有致突变作用"}, {"probability": {"variance": 4.8e-05, "average": 0.995891, "min": 0.958894}, "location": {"width": 890, "top": 469, "height": 40, "left": 158}, "words": "生殖毒性:雌、雄大鼠在给予剂量达60mg/kg/日(根据体表面积推算,相当于人最大用药剂量的3倍)"}, {"probability": {"variance": 0.002947, "average": 0.987289, "min": 0.614587}, "location": {"width": 945, "top": 517, "height": 38, "left": 117}, "words": "未发现其生育能力降低。有报道,本品能通过小鼠的胎盘,并已证实,当给予大鼠剂量达200mg/g/日(根"}, {"probability": {"variance": 5.2e-05, "average": 0.994893, "min": 0.964748}, "location": {"width": 944, "top": 559, "height": 42, "left": 115}, "words": "据体表面积推算,相当于人最大用药剂量的11倍)时,本品具有胚胎毒性。该剂量产生的胚胎毒性被认为是"}, {"probability": {"variance": 0.001827, "average": 0.989455, "min": 0.704804}, "location": {"width": 946, "top": 609, "height": 40, "left": 113}, "words": "由于增加了胚胎的吸收所致,而且此剂量对母体也产生了以下影响,如运动失调、震颤、惊厥和明显的体重"}, {"probability": {"variance": 0.001357, "average": 0.987868, "min": 0.758443}, "location": {"width": 942, "top": 655, "height": 39, "left": 116}, "words": "下降。兔子给予剂量为16mg/kg/日(根据体表面积推算,相当于人最大用药剂量的5倍)时,未发现有胚胎"}, {"probability": {"variance": 0.000131, "average": 0.994657, "min": 0.936177}, "location": {"width": 940, "top": 700, "height": 38, "left": 116}, "words": "毒性,但已有证据表明:动物出现12或13根肋骨的胚胎比率的改变,同窝仔的正常比率约为50:50,而用"}, {"probability": {"variance": 0.006057, "average": 0.980579, "min": 0.424599}, "location": {"width": 940, "top": 748, "height": 38, "left": 116}, "words": "本品处理后的比率为80:20在产前和产后的生殖毒性研究中,孕鼠给予本品剂量分别为30、60和200mg/kg/"}, {"probability": {"variance": 0.000323, "average": 0.993171, "min": 0.874255}, "location": {"width": 939, "top": 790, "height": 41, "left": 116}, "words": "日(根据体表面积推算,分别相当于人最大用药剂量的1.7、3.4和11倍),在受孕期,两个高剂量组已发"}, {"probability": {"variance": 0.006564, "average": 0.975308, "min": 0.571275}, "location": {"width": 932, "top": 840, "height": 36, "left": 112}, "words": "现母体毒性。在产后第2-4天期间,幼仔死亡率增加。另外在两个较高剂量组,还发现F1代动物生育力降低"}, {"probability": {"variance": 6.3e-05, "average": 0.993979, "min": 0.965198}, "location": {"width": 575, "top": 886, "height": 30, "left": 114}, "words": "所以在妊娠期,应权衡对母体和胚胎的利大于弊时,才可使用本"}, {"probability": {"variance": 0.001623, "average": 0.987124, "min": 0.831278}, "location": {"width": 318, "top": 932, "height": 25, "left": 153}, "words": "致癌性:尚未进行动物致癌性的研究"}, {"probability": {"variance": 0.011823, "average": 0.924513, "min": 0.703509}, "location": {"width": 275, "top": 904, "height": 48, "left": 692}, "words": "受理号CHB68"}, {"probability": {"variance": 8.6e-05, "average": 0.993125, "min": 0.974099}, "location": {"width": 127, "top": 979, "height": 26, "left": 119}, "words": "【药代动力学!"}, {"probability": {"variance": 0.004735, "average": 0.947733, "min": 0.75611}, "location": {"width": 130, "top": 971, "height": 31, "left": 812}, "words": "2009-06-23"}, {"probability": {"variance": 8.6e-05, "average": 0.987098, "min": 0.978378}, "location": {"width": 46, "top": 1027, "height": 24, "left": 154}, "words": "据Ph"}, {"probability": {"variance": 0.000954, "average": 0.94759, "min": 0.916703}, "location": {"width": 86, "top": 1028, "height": 22, "left": 301}, "words": " Desk Reft"}, {"probability": {"variance": 0.041833, "average": 0.840983, "min": 0.363316}, "location": {"width": 607, "top": 1020, "height": 49, "left": 449}, "words": "57版介绍,虽然盐酸金刚方学参"}, {"probability": {"variance": 1.9e-05, "average": 0.997658, "min": 0.977341}, "location": {"width": 633, "top": 1072, "height": 27, "left": 114}, "words": "没有有效的药效学数据来建立一个血浆浓度与它的抗病毒效果之间的关系"}, {"probability": {"variance": 0.044828, "average": 0.839704, "min": 0.392095}, "location": {"width": 891, "top": 1108, "height": 41, "left": 152}, "words": "单量10mg盐酸金刚乙胺口服吸收后血药浓度峰锋值74±2g/ml围45药品到思"}, {"probability": {"variance": 0.000891, "average": 0.988769, "min": 0.865128}, "location": {"width": 934, "top": 1160, "height": 39, "left": 113}, "words": "40岁之间的健康成年人,在6±1小时后可达到高峰。这种剂量在上述群体的体内半衰期是25.4±63h(范"}, {"probability": {"variance": 0.007807, "average": 0.969108, "min": 0.479887}, "location": {"width": 935, "top": 1208, "height": 36, "left": 113}, "words": "围13~65h),同一剂量在71至79岁的健康人实验中,体内清除半衰期是32±6h(范围20~65h)。在18"}, {"probability": {"variance": 0.003343, "average": 0.976783, "min": 0.64946}, "location": {"width": 913, "top": 1253, "height": 37, "left": 112}, "words": "至70岁的健康志愿者每日服用二次100mg的金刚乙胺,10天后,时量曲线下面积AUC值比服用单一剂量100"}, {"probability": {"variance": 0.005967, "average": 0.980641, "min": 0.577312}, "location": {"width": 520, "top": 1303, "height": 25, "left": 112}, "words": "预计的高出近30%。在稳定状态下,最低血药浓度范围在118"}, {"probability": {"variance": 0.000154, "average": 0.995559, "min": 0.943588}, "location": {"width": 360, "top": 1305, "height": 29, "left": 685}, "words": "g/ml研究发现在药代动力学方面,这些"}, {"probability": {"variance": 8.8e-05, "average": 0.995301, "min": 0.944139}, "location": {"width": 934, "top": 1345, "height": 35, "left": 110}, "words": "患者并没有年龄之间的差异。然而,在对50~60岁组,61~70岁组,71~79岁组健康的老年受试者进行对"}, {"probability": {"variance": 0.007588, "average": 0.980867, "min": 0.360896}, "location": {"width": 923, "top": 1391, "height": 34, "left": 111}, "words": "比研究中发现,71~79岁组的在稳定状态下的平均AC值、峰值浓度和消除半衰期值比其它二组高出20~30%"}, {"probability": {"variance": 0.00074, "average": 0.990764, "min": 0.868527}, "location": {"width": 843, "top": 1436, "height": 35, "left": 108}, "words": "对60~102岁需要家庭护理的患者,在稳定状态下浓度比健康的青年人和中老年人组高出2~4倍"}, {"probability": {"variance": 0.000384, "average": 0.990199, "min": 0.891232}, "location": {"width": 892, "top": 1482, "height": 36, "left": 150}, "words": "金刚乙胺对儿童全面的药物动力学还没有被建立。给一组(10个人)4~8岁的儿童6.6mg/kg剂量的盐"}, {"probability": {"variance": 0.003833, "average": 0.979243, "min": 0.622477}, "location": {"width": 915, "top": 1529, "height": 36, "left": 108}, "words": "酸金刚乙肢糖浆剂,5至6小时后,金刚乙胺的血浆浓度范围在446~988ng/ml,24小时后,范围在170"}, {"probability": {"variance": 0.004618, "average": 0.982064, "min": 0.592013}, "location": {"width": 657, "top": 1577, "height": 27, "left": 111}, "words": "44ng/ml,在某些儿童中最后一次服药后72小时血浆中仍能测到该药物浓度"}, {"probability": {"variance": 0.009745, "average": 0.951231, "min": 0.673794}, "location": {"width": 211, "top": 1599, "height": 39, "left": 934}, "words": "第5页共6页仅供存档"}], "language": 3}